Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-14-006723
Filing Date
2014-06-11
Accepted
2014-06-11 17:19:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 27237
2 GRAPHIC g692340g38t44.jpg GRAPHIC 2655
  Complete submission text file 0000950123-14-006723.txt   31928
Mailing Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005 415-287-2410
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)